INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 455m ago
House PTR55m ago
SEC 13F55m ago
Robinhood Chain55m ago

Results

71,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
Page 26 of 1778
← PrevNext →
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

20
BM
Brown Monica M.EVP, Chief Legal Officer
LIILENNOX INTERNATIONAL INC
Option exercise
M$214K
831 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

20
GJ
Gowans JasonEVP and CDTO
LEVILEVI STRAUSS & CO
Open-market sale
SELL$83K
3,494 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
HK
Hillesland KevinSVP, Structured Finance
GATXGATX CORP
Option exercise
M$146K
1,900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

20
RE
Robinson ElliottDirector
HNGEHinge Health, Inc.
Open-market sale
SELL—
0 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$1.06M
11.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$2.59M
26.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
HM
Hugh MiltonEVP, Sales
VIKViking Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$1.80M
20.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
CP
Conser Jonathan P.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$483K
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
GG
Gallara GiovanniSee Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$537K
13.1K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$1.09M
1,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
NT
Newton Raymond TannerEVP & Chief Financial Officer
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$302K
7,378 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
DA
deLorimier John A.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$514K
12.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
MR
McAndrew Douglas R.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$483K
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
KR
Kasnavi RezaEVP, Chief Ops & Tech Officer
SWKSSKYWORKS SOLUTIONS, INC.
Tax withholding
F$588K
7,238 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
DA
Devasia Thomas A.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$483K
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
GM
Gilbert Greg M.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$483K
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
RF
Ryan Timothy F.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$483K
11.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
RD
Rhine Michael D.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$322K
7,870 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
KD
Kendall DanielleSee Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$322K
7,870 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
BS
Buchanan Christopher ScottChief Financial Officer
SLMTSolmate Infrastructure PLC
Grant or award
A—
80.0K sh
Oct 1, 2026Nov 6, 2026
traded Oct 1, 2026
+36dSEC Form 4

Evidence

19
OS
Orn Jonsson SigurgeirChief Technology Officer
BETRBetter Home & Finance Holding Co
Option exercise
M—
3,906 sh
Nov 1, 2026Nov 6, 2026
traded Nov 1, 2026
+5dSEC Form 4

Evidence

19
GC
Goldberg ChenEVP, Product & Engineering
CRWVCoreWeave, Inc.
Open-market sale
SELL$32K
695 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
DA
Durham Karilee ASVP, Human Resources
SWKSSKYWORKS SOLUTIONS, INC.
Tax withholding
F$364K
4,481 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
BG
Baugnon Robert GSenior VP, Personnel and Admin
ROADConstruction Partners, Inc.
Tax withholding
F$276K
2,782 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$2.85M
29.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
KD
Krulik DouglasCAO and Interim CFO
PETSPETMED EXPRESS INC
Tax withholding
F$4,966
3,246 sh
Sep 27, 2026Nov 6, 2026
traded Sep 27, 2026
+40dSEC Form 4

Evidence

19
MS
Malhotra ShawnChief Technology Officer
RKTRocket Companies, Inc.
Tax withholding
F$766K
51.7K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

19
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$1.85M
59.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
KA
Kosuth Michael A.See Remarks
CONConcentra Group Holdings Parent, Inc.
Tax withholding
F$535K
13.1K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
PD
Puckett Jeffrey DavidChief Operating Officer
TYLTYLER TECHNOLOGIES INC
Option exercise
M$909K
5,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
WJ
Wheeler Kevin J.Director
AOSSMITH A O CORP
Option exercise
M$736K
14.7K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
BL
Bogart Stacy LSVP-Chief Legal Officer
WGOWINNEBAGO INDUSTRIES INC
Option exercise
M$311K
9,823 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
ID
Ishaug Anthony DCHIEF FINANCIAL OFFICER
WINAWINMARK CORP
Option exercise
M$477K
3,800 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
BR
Brooks Judson RyanSVP and General Counsel
ROADConstruction Partners, Inc.
Tax withholding
F$290K
2,926 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
EM
Ehrlichman MattDirector, CEO, CHAIRMAN AND FOUNDER, 10% Owner
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
5,701 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence